{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:10:20Z","timestamp":1793067020498,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.beem.2012.11.002","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T02:05:24Z","timestamp":1356141924000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Hormonal contraceptives and venous thromboembolism: An epidemiological update"],"prefix":"10.1016","volume":"27","author":[{"given":"Genevieve","family":"Plu-Bureau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Maitrot-Mantelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Hugon-Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2012.11.002_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France","volume":"83","author":"Oger","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"4","author":"Naess","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib3","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib4","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib5","unstructured":"FDA. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints, final report 111022v2. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM277384.pdf."},{"key":"10.1016\/j.beem.2012.11.002_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2011.02.013","article-title":"Current issues and available options in combined hormonal contraception","volume":"84","author":"Bitzer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.beem.2012.11.002_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(99)00101-8","article-title":"Nomenclature of the gonane progestins","volume":"60","author":"Edgren","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1345\/aph.1Q216","article-title":"Estradiol valerate\/dienogest: a novel oral contraceptive","volume":"45","author":"Whalen","year":"2011","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.beem.2012.11.002_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2012.11.002_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/13625187.2011.554923","article-title":"Inhibition of ovulation by NOMAC\/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17\u03b2-oestradiol: a double-blind, randomised, dose-finding pilot study","volume":"16","author":"Chabbert-Buffet","year":"2011","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"1","key":"10.1016\/j.beem.2012.11.002_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007541.pub2","article-title":"Progestin-only pills for contraception","author":"Grimes","year":"2010","journal-title":"Cochrane Database of Systemic Review"},{"key":"10.1016\/j.beem.2012.11.002_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptives oestrogen and progestin potencies and the incidence of deep venous thromboembolism","volume":"133","author":"Gerstman","year":"1991","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.beem.2012.11.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13625187.2011.643836","article-title":"Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis","volume":"17","author":"Martinez","year":"2012","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.002_bib17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17\u03b2-estradiol, compared with those of levonorgestrel\/ethinyl estradiol. A double-blind, randomised study","volume":"105","author":"Gaussem","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"Agren","year":"2011","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1016\/j.beem.2012.11.002_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptibes","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.321.7259.477","article-title":"Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database","volume":"321","author":"Farmer","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","article-title":"The differential risk of oral contraceptives: the impact of full exposure history","volume":"14","author":"Lewis","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2012.11.002_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.159.1.65","article-title":"Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained b diagnostic suspicion and referral bias","volume":"159","author":"Bloemenkamp","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2012.11.002_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control stud","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib25","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international case-control study","volume":"346","author":"Poulter","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/5.6.688","article-title":"Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus Database","volume":"5","author":"Farmer","year":"1999","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.beem.2012.11.002_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.11.002_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on oral contraceptives based on 142,475 women years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib38","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"340","author":"Jick","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib39","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"340","author":"Parkin","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib40","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospir\u00e9none-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib41","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone and levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.896","article-title":"Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database","volume":"13","author":"Seaman","year":"2004","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.beem.2012.11.002_bib44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.280.6224.1157","article-title":"Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations","volume":"280","author":"Meade","year":"1980","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2010.04148.x","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"9","author":"van Hylckama Vlieg","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib46","first-page":"549","article-title":"Safety of combined oral contraceptives containing pills","volume":"347","author":"Plu-Bureau","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib47","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc-Gelas","year":"2004","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib48","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second-and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beem.2012.11.002_bib49","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein-C: a randomised cross-over study","volume":"97","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib50","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlin","year":"2002","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.beem.2012.11.002_bib51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1538-7836.2012.04720.x","article-title":"Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives","volume":"10","author":"Raps","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35\u00a0\u03bcg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35\u00a0\u03bcg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.12.016","article-title":"Ortho EVRA\u00ae and venous thromboembolism: an update","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.beem.2012.11.002_bib56","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib57","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2012.11.002_bib58","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal on hemostatic factors and hepatic proteins in a randomised cross-over study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2012.11.002_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study","volume":"3","author":"Fleischer","year":"2009","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.beem.2012.11.002_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2009.05.131","article-title":"Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis","volume":"1","author":"Van Vliet","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2007.10.004","article-title":"Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables","volume":"77","author":"Kluft","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00016340902730375","volume":"88","author":"Bergandal","year":"2009","journal-title":"Acta Obstetrica Gynecologica"},{"key":"10.1016\/j.beem.2012.11.002_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.thromres.2012.02.042","article-title":"Progestin-only contraception and venous thromboembolism","volume":"129","author":"Blanco-Molina","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.beem.2012.11.002_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib65","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Areteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1016\/j.beem.2012.11.002_bib66","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"334","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.11.002_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The thrombosis: risk and economic assessment of Thrombophilia Screening (TREATS) study","volume":"94","author":"Wu","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.beem.2012.11.002_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-onl contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2011.06.008","article-title":"Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives","volume":"84","author":"Vaillant-Roussel","year":"2011","journal-title":"Cpontraception"},{"key":"10.1016\/j.beem.2012.11.002_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","article-title":"Pregnane progestin contraception in systemic lupus erythematossus: a longitudinal study of 187 patients","volume":"83","author":"Chabbert-Buffet","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2012.11.002_bib71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factors levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thrombosis and Haemostasis"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:45:35Z","timestamp":1761497135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X12001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1521690X12001145"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2012.11.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal contraceptives and venous thromboembolism: An epidemiological update","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2012.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}